Zobrazeno 1 - 10
of 494
pro vyhledávání: '"L. Brecher"'
Autor:
Young, Graham A. R.
Publikováno v:
Hematological Oncology; June 1999, Vol. 17 Issue: 2 p53-83, 31p
Publikováno v:
Hematological Oncology; March 1999, Vol. 17 Issue: 1 p11-29, 19p
Publikováno v:
The Journal of Pathology; March 2000, Vol. 190 Issue: 4 p520-520, 1p
Autor:
Lu Chen, Floyd Daniel Armstrong, Kathleen J. Helton, Beverly Bell, Patricia K. Duffner, Martin L. Brecher, Allen R. Chauvenet
Publikováno v:
Journal of Pediatric Hematology/Oncology. 36:8-15
Concerns about long-term methotrexate (MTX) neurotoxicity in the 1990s led to modifications in intrathecal (IT) therapy, leucovorin rescue, and frequency of systemic MTX administration in children with acute lymphoblastic leukemia. In this study, neu
Publikováno v:
American Journal of Obstetrics and Gynecology. 220:S716
Publikováno v:
American Journal of Obstetrics and Gynecology. 220:S717
Publikováno v:
Paediatric and Perinatal Epidemiology. 19:152-164
Infectious disease histories were evaluated in a population-based case-control study of childhood acute lymphoblastic leukaemia (ALL) as it has been hypothesised that delays in early infections are associated with an increased risk of disease. Allerg
Autor:
AnneMarie W. Block, Martin L. Brecher, Carleton C. Stewart, George Deeb, Meir Wetzler, Maurice Barcos, Rina Kansal
Publikováno v:
American Journal of Clinical Pathology. 121:512-525
We describe 15 patients (9 children) with precursor B-cell (pB) acute lymphoblastic leukemia (ALL) with surface immunoglobulin (sIg) light chain restriction revealed by flow cytometric immunophenotyping (FCI). The same sIg+ immunophenotype was presen
Autor:
James F. Holland, James M. Boyett, Martin L. Brecher, Ronald Dubowy, Jimmie C. Holland, Harold M. Maurer, Alice B. Kornblith, Arvin S. Glicksman, Beat Lenherr, Dana Jones, Faith Kung, James M. Hill, Arnold Freeman
Publikováno v:
Cancer. 82:208-218
BACKGROUND Although previous research has delineated medical, cognitive, and neuropsychologic late effects of central nervous system (CNS) prophylaxis for childhood acute lymphoblastic leukemia (ALL), it has been difficult to draw conclusions about t
Autor:
Sharon B. Murphy, Max J. Coppes, Costan W. Berard, J J Shuster, Martin L. Brecher, Molly R. Schwenn, Michael P. Link, W. Paul Bowman
Publikováno v:
Medical and Pediatric Oncology. 29:526-533
Background The Pediatric Oncology Group (POG) conducted a two-arm, randomized study for the treatment of children and adolescents with stage III small, non-cleaved cell lymphoma (SNCCL). Regimen A, based on the group's previous best treatment for thi